National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT]
NCT01104935
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
275
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
trastuzumab monotherapy
DRUG:
trastuzumab and chemotherapy
Sponsor
Comprehensive Support Project for Oncology Research